Industry litigation – Page 19
-
Business
J&J puts trial data in independent hands
Yale University’s YODA seeks to help pharma avoid the dark side by acting as gatekeeper for patient records
-
Business
Stolen silicone secrets land worker in jail
Former Wacker employee sold formulae to South Korean firm KCC Silicones
-
Business
California and Chemtura clash over fire safety
New rules eliminate the need for flame retardants in furniture
-
Business
US blocks imports from fourth Ranbaxy plant
FDA bans import of active ingredients from factory in Toansa, India
-
Business
US chemical spill contaminates water supplies
Life beginning to return to normal for locals after being without potable water for several days
-
Business
Novartis in the spotlight in mis-selling investigations
Crackdown on pharma marketing continues with US and Japanese cases
-
Business
Deadly explosion at Japanese silicon plant
Five killed and several more injured at Mitsubishi Materials site
-
-
-
Business
AstraZeneca claims quashed in heartburn drug patent case
Nexium rival does not infringe on patent, court rules
-
Business
Chinese police seize £222m of fake drugs
1300 people are arrested in a nationwide crackdown on counterfeit medicines
-
Business
Court overturns approval to grow GM potato in Europe
Europe’s second highest court rules that European commission did not follow its own rules when giving Amflora the green light
-
Business
New wave of hepatitis C drugs hits US shore
J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
-
Business
US turnaround on Avandia restrictions
Researchers accuse regulator of face-saving U-turn over diabetes medication safety
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
Business
Mis-selling lands J&J with $2.2bn fine
Company found guilty of promoting three drugs for unapproved uses
-
Business
Pharma manufacturing woes dog industry
Regulators are stepping up inspections, and discovering ever more problems
-
News
Another drug suspension overturned in India
Safety concerns put sales of antidepressant Deanxit on ice until firms petitioned a high court
-
Business
Lundbeck appeals European antitrust fine
Danish pharmaceutical claims €93.8 million pay-for-delay penalty was the result of ‘serious legal and factual errors’